您的位置: 首页 > 农业专利 > 详情页

Anti-cross-linking agents and methods for inhibiting cross-linking of injectable hy-drogel formulations
专利权人:
The General Hospital Corporation DBA Massachusetts General Hospital
发明人:
Muratoglu, Orhun K.,Oral, Ebru,Bodugoz-Senturk, Hatice
申请号:
AU2012216443
公开号:
AU2012216443A1
申请日:
2012.08.27
申请国别(地区):
AU
年份:
2012
代理人:
摘要:
#$%^&*AU2012216443A120120913.pdf#####ABSTRACT The invention relates to cross-link-resistant injectable hydrogel formulations and methods of partially or practically wholly inhibiting injectable hydrogel formulations from cross-linking during irradiation using anti-cross-linking 5 agents, which facilitates injectability of the hydrogel formulation. The invention also relates to methods of making the cross-link-resistant, for example, irradiation cross-link resistant, injectable hydrogel formulations, and methods of administering the same in treating a subject in need.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充